Julie Holder is an experienced preclinical scientist. Having 26 years of cell culture experience working with primary, immortalised and iPS cells with managerial responsibility of running a cellular group responsible for delivering predictive assays for attrition reduction. I am currently responsible for establishing and managing internal and external projects within Roslin Cell Sciences working to support the discovery and development of new assays utilising differentiated iPS cells.
Để lại đánh giá